Clinical proteomics: Promises, challenges and limitations of affinity arrays

Proteomics - Clinical Applications

Volumn 9, Issue 3-4, 2015, Pages 342-347

  Betzen, Christian ^a,b   Alhamdani, Mohamed Saiel Saeed ^a   Lueong, Smiths ^a   Schröder, Christoph ^a,c   Stang, Axel ^d   Hoheisel, Jörg D ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c SCIOMICS GMBH   (Germany)

^d ASKLEPIOS HOSPITAL BARMBEK   (Germany)

Author keywords

Affinity profiling; Antibodies; Immunoassay; Interaction; Protein microarrays

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

DNA SEQUENCE; HUMAN; MEASUREMENT ACCURACY; NOTE; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUALITY CONTROL; REPRODUCIBILITY; SENSITIVITY ANALYSIS; PROCEDURES;

HUMANS; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 84928081356     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400156     Document Type: Note

References (28)

1. The International Cancer Genome Consortium, International network of cancer genome projects. Nature 2010, 464, 993-998.
2. Kim, M.-S., Pinto, S. M., Getnet, D., Nirujogi, R. S. et al., A draft map of the human proteome. Nature 2014, 509, 575-581.
3. Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. et al., Mass-spectrometry-based draft of the human proteome. Nature 2014, 509, 582-587.
4. Fagerberg, L., Hallström, B. M., Oksvold, P., Kampf, C. et al., Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell. Prot. 2014, 13, 397-406.
5. Strathmann, F. G., Hoofnagle, A. N., Current and future applications of mass spectrometry to the clinical laboratory. Am. J. Clin. Pathol. 2011, 136, 609-616.
6. Meng, Q. H., Mass spectrometry applications in clinical diagnostics. J. Clinic. Exp. Pathol. 2013, S6, e001.
7. Poste, G., Bring on the biomarkers. Nature 2011, 469, 156-157.
8. Syafrizayanti, Betzen, C., Hoheisel, J. D., Kastelic, D., Methods for analysing and quantifying protein-protein interactions. Exp. Rev. Prot. 2014, 11, 107-120.
9. Schmidt, R., Jacak, J., Schirwitz, C., Stadler, V. et al., Single-molecule detection on a protein-array assay platform for the exposure of a tuberculosis antigen. J. Prot. Res. 2011, 10, 1316-1322.
10. MacBeath, G., Schreiber, S. L., Printing proteins as microarrays for high-throughput function determination. Science 2000, 289, 1760-1763.
11. He, M., Taussig, M. J., Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). Nucleic Acid. Res. 2001, 29, e73.
12. Ramachandran, N., Hainsworth, E., Bhullar, B., Eisenstein, S. et al., Self-assembling protein microarrays. Science 2004, 305, 86-90.
13. Angenendt, P., Kreutzberger, J., Glokler, J., Hoheisel, J. D., Generation of high density protein microarrays by cell-free in situ expression of unpurified PCR products. Mol. Cell. Proteomics 2006, 5, 1658-1666.
14. Li, B., Jiang, L., Song, Q., Yang, J. et al., Protein microarray for profiling antibody responses to Yersinia pestis live vaccine. Infect. Immun. 2005, 73, 3734-3739.
15. Quintanaa, F. J., Fareza, M. F., Vigliettaa, V., Iglesias, A. H. et al., Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl. Acad. Sci. USA 2008, 106, 18889-18894.
16. Patwa, T., Li, C., Simeone, D. M., Lubman, D. M., Glycoprotein analysis using protein microarrays and mass spectrometry. Mass. Spectom. Rev. 2010, 29, 830-844.
17. Sachse, R., Dondapati, S. K., Fenz, S. F., Schmidt, T., Kubick, S., Membrane protein synthesis in cell-free systems: from bio-mimetic systems to bio-membranes. FEBS Lett. 2014, 588, 2774-2781.
18. Brennan, D. J., O'Connor, D. P., Rexhepaj, E., Ponten, F., Gallagher, W. M., Antibody-based proteomics, fast-tracking molecular diagnostics in oncology. Nat. Rev. Cancer 2010, 10, 605-617.
19. Schröder, C., Jacob, A., Tonack, S., Radon, T. et al., Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-specific antibodies. Mol. Cell. Proteomics 2010, 9, 1271-1280.
20. Wingren, C., Sandström, A., Segersvärd, R., Carlsson, A. et al., Identification of serum biomarker signatures associated with pancreatic cancer. Cancer Res. 2012, 72, 2481-2490.
21. Mirus, J. E., Zhang, Y., Hollingsworth, M. A., Solan, J. L. et al., Spatiotemporal proteomic analyses during pancreas cancer progression identifies STK4 as a novel candidate biomarker for early stage disease. Mol. Cell. Proteomics 2014, 13, 3484-3496.
22. Flajnik, M. F., Deschacht, N., Muyldermans, S., A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels? PLoS Biol. 2011, 9, e1001120.
23. Paweletz, C.P., Charboneau, L., Bichsel, V. E., Simone, N. L. et al., Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20, 1981-1989.
24. Akbani, R., Ng, P. K. S., Werner, H. M. J., Shahmoradgoli, M. et al., A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat. Commun. 2014, 5, 3887.
25. Hoadley, K. A., Yau, C., Wolf, D. M., Cherniack, A. D. et al., Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 2014, 158, 929-944.
26. Olsson, N., James, P., Borrebaeck, C. A. K., Wingren, C., Quantitative proteomics targeting classes of motif-containing peptides using immunoaffinity-based mass spectrometry. Mol. Cell. Proteomics 2012, 11, 342-354.
27. Bussom, S., Saif, M. W., Methods and rationale for the early detection of pancreatic cancer. J. Pancreas 2010, 11, 128-130.
28. Schwenk, J. M., Igel, U., Kato, B. S., Nicholson, G. et al., Comparative protein profiling of serum and plasma using an antibody suspension bead array approach. Proteomics 2010, 10, 532-540.